Endometrial Cancer Trial, Recruiting NCT03853915 Sponsor: University Health Network, Toronto Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT03853915
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a specific type of cervical cancer (squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma), confirmed by a tissue test, at a certain stage of the disease (FIGO stage IB to IVA).
  • You are planned to receive a full course of radiation therapy combined with a chemotherapy drug called cisplatin.
  • You are 18 years of age or older.

Who may not be able to join:

  • Your cancer has spread to distant parts of the body (though some cases with affected lymph nodes in a specific area near the aorta may still be considered — confirm with trial site).
  • You have already received any cancer treatment for your cervical cancer.
  • Your cervical cancer is a different type than those listed above, such as small cell or serous carcinoma.
  • You are unable to have a type of imaging scan called an 18FDG PET-CT scan for medical reasons.
  • You have a medical condition that means you cannot safely receive radiation therapy (for example, severe Crohn's disease).
  • You have a medical condition that means you cannot safely receive chemotherapy (for example, permanent kidney failure).
  • You have a history of another serious cancer, unless it was a non-melanoma skin cancer, or another cancer that was fully treated with no signs of return for at least 5 years.
  • You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 416 946 4501

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 April 2019
Est. completion
30 December 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Progression-free survival rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov